FDA Approves Smallpox Vaccine for Monkeypox Despite High Transmission Risk
The FDA approved a vaccine (ACAM2000) in August for monkeypox despite the high risk of virus transmission from the vaccinated individual to others. The vaccine insert states, “Death has also been reported in unvaccinated contacts accidentally infected by individuals who have been vaccinated.” The vaccine has been approved for smallpox since 2007 and the CDC…Continue reading FDA Approves Smallpox Vaccine for Monkeypox Despite High Transmission Risk